530 related articles for article (PubMed ID: 15743841)
1. Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue.
Kurlawalla-Martinez C; Stiles B; Wang Y; Devaskar SU; Kahn BB; Wu H
Mol Cell Biol; 2005 Mar; 25(6):2498-510. PubMed ID: 15743841
[TBL] [Abstract][Full Text] [Related]
2. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
[TBL] [Abstract][Full Text] [Related]
3. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes.
Tang X; Powelka AM; Soriano NA; Czech MP; Guilherme A
J Biol Chem; 2005 Jun; 280(23):22523-9. PubMed ID: 15824124
[TBL] [Abstract][Full Text] [Related]
4. Decreased Akt kinase activity and insulin resistance in C57BL/KsJ-Leprdb/db mice.
Shao J; Yamashita H; Qiao L; Friedman JE
J Endocrinol; 2000 Oct; 167(1):107-15. PubMed ID: 11018758
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats.
Satoh H; Nguyen MT; Miles PD; Imamura T; Usui I; Olefsky JM
J Clin Invest; 2004 Jul; 114(2):224-31. PubMed ID: 15254589
[TBL] [Abstract][Full Text] [Related]
6. Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected].
Stiles B; Wang Y; Stahl A; Bassilian S; Lee WP; Kim YJ; Sherwin R; Devaskar S; Lesche R; Magnuson MA; Wu H
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2082-7. PubMed ID: 14769918
[TBL] [Abstract][Full Text] [Related]
7. Muscle-specific Pten deletion protects against insulin resistance and diabetes.
Wijesekara N; Konrad D; Eweida M; Jefferies C; Liadis N; Giacca A; Crackower M; Suzuki A; Mak TW; Kahn CR; Klip A; Woo M
Mol Cell Biol; 2005 Feb; 25(3):1135-45. PubMed ID: 15657439
[TBL] [Abstract][Full Text] [Related]
8. PTEN does not modulate GLUT4 translocation in rat adipose cells under physiological conditions.
Mosser VA; Li Y; Quon MJ
Biochem Biophys Res Commun; 2001 Nov; 288(4):1011-7. PubMed ID: 11689011
[TBL] [Abstract][Full Text] [Related]
9. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice.
Butler M; McKay RA; Popoff IJ; Gaarde WA; Witchell D; Murray SF; Dean NM; Bhanot S; Monia BP
Diabetes; 2002 Apr; 51(4):1028-34. PubMed ID: 11916922
[TBL] [Abstract][Full Text] [Related]
11. Resistin is regulated by C/EBPs, PPARs, and signal-transducing molecules.
Song H; Shojima N; Sakoda H; Ogihara T; Fujishiro M; Katagiri H; Anai M; Onishi Y; Ono H; Inukai K; Fukushima Y; Kikuchi M; Shimano H; Yamada N; Oka Y; Asano T
Biochem Biophys Res Commun; 2002 Nov; 299(2):291-8. PubMed ID: 12437985
[TBL] [Abstract][Full Text] [Related]
12. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
[TBL] [Abstract][Full Text] [Related]
13. Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity.
Sasaoka T; Wada T; Tsuneki H
Pharmacol Ther; 2006 Dec; 112(3):799-809. PubMed ID: 16842857
[TBL] [Abstract][Full Text] [Related]
14. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes.
Nakashima N; Sharma PM; Imamura T; Bookstein R; Olefsky JM
J Biol Chem; 2000 Apr; 275(17):12889-95. PubMed ID: 10777587
[TBL] [Abstract][Full Text] [Related]
16. Pancreas-specific Pten deficiency causes partial resistance to diabetes and elevated hepatic AKT signaling.
Tong Z; Fan Y; Zhang W; Xu J; Cheng J; Ding M; Deng H
Cell Res; 2009 Jun; 19(6):710-9. PubMed ID: 19365404
[TBL] [Abstract][Full Text] [Related]
17. Regulation of sensitivity to TRAIL by the PTEN tumor suppressor.
Whang YE; Yuan XJ; Liu Y; Majumder S; Lewis TD
Vitam Horm; 2004; 67():409-26. PubMed ID: 15110188
[TBL] [Abstract][Full Text] [Related]
18. Impact of lipid phosphatases SHIP2 and PTEN on the time- and Akt-isoform-specific amelioration of TNF-alpha-induced insulin resistance in 3T3-L1 adipocytes.
Ikubo M; Wada T; Fukui K; Ishiki M; Ishihara H; Asano T; Tsuneki H; Sasaoka T
Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E157-64. PubMed ID: 19001549
[TBL] [Abstract][Full Text] [Related]
19. Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation.
Liu JL; Sheng X; Hortobagyi ZK; Mao Z; Gallick GE; Yung WK
Mol Cell Biol; 2005 Jul; 25(14):6211-24. PubMed ID: 15988030
[TBL] [Abstract][Full Text] [Related]
20. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
